New Study Conducted at Sheppard Pratt Finds Psilocybin-Assisted Therapy May Reduce Chronic Suicidal IdeationMorningStar·May 26 at 12:50 PMMNMD0.00%CMPS+6.15%
Trump Wants to Give Psychedelics Stocks a Boost. Can This Leading Company Deliver?Barchart Option·Apr 28 at 02:45 PMCMPS+6.15%ATAI0.00%
FDA Moves To Fast-Track Psychedelic Therapies For Mental Healthrttnews·Apr 24 at 04:50 PMATAI0.00%CYBN0.00%
Trump’s Rogan-inspired psychedelics order stokes cautious optimismThehill·Apr 22 at 10:05 PMSEEL0.00%SEELQ0.00%
Trump Order To Accelerate Treatments For Serious Mental Illnessrttnews·Apr 20 at 06:37 AMCMPS+6.15%MNMD0.00%
After Trump signed the executive order to expedite the treatment of severe mental illnesses, Psychedelic Pharmaceuticals shares roseAASTOCKS·Apr 20 at 06:23 AMDFTX+5.53%ATAI0.00%
Trump: Accelerate access to research on psychedelic drugsWallstreetcn·Apr 18 at 08:14 AMGHRS+1.43%MNMD0.00%
Trump orders faster review of psychedelic drugs including ibogaineBusiness Standard·Apr 18 at 03:51 AMATAI0.00%CMPS+6.15%
Cybin Inc. (NASDAQ:HELP) Given Average Recommendation of "Buy" by BrokeragesMarket Beat·Apr 13 at 09:39 AMCYBN0.00%HELP+2.91%
10:50 ETCNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisionsprnewswire·Mar 9 at 09:52 AMXBI+2.40%BBH-0.30%
Cybin’s Helus Pharma Posts Strong Phase 2 Data for HLP004 in Hard-to-Treat AnxietyTip Ranks·Mar 5 at 07:17 AMXBI+2.40%BBH-0.30%
